sars cov 2 detection kit

sars cov 2 detection kit

Invitrogen Colorimetric ReadiLAMP™ kit, SARS-CoV-2

This kit uses a Loop-Mediated Isothermal Amplification (LAMP)- based solution for rapid SARS-CoV-2 detection and surveillance.
  • Detection is simple, intuitive and fast: colorimetric LAMP reaction changes color from purple to blue if SARS-target is present. No instrumentation is required for this assay, except for a 65℃ heat source.
  • Utilizes non-invasive saliva samples or swab samples
  • Ability to detect varying SARS-CoV-2 viral strains
  • It can be utilized either of two ways – direct assay using crude samples or assay based on RNA purified from saliva and swabs.
  • It allows input of up to 50% purified RNA per LAMP reaction to achieve maximal sensitivity in SARS-CoV-2 detection. See kit performance data.
  • Process 1-96 samples at a time: Customers can process more samples with the same number of technicians, using individual tubes, tubes strips, or 96 well plates.

Abstract

In this current pandemic of coronavirus disease 2019 (COVID-19), prompt interventions in terms of early detection and clinical management along with isolation of positive cases is of utmost importance. This helps to limit not only the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections but also the morbidity and mortality associated with it. Different strategies for screening of COVID-19 in containment zones and non-containment areas include testing of symptomatic patients and their contacts in fever clinics, hospital-based testing, testing on demand and population-based screening. The choice of tests like reverse-transcription polymerase chain reaction (RT-PCR), rapid antigen testing (RAT) or antibody test depends upon these strategies and also the turnaround time. Currently, RT-PCR is considered the gold standard for COVID-19 detection. This commentary provides the insights and experiences on COVID-19 diagnosis by RT-PCR. The utility of this test is limited by several false positive, false negative and inconclusive results at early stages of infection, scarcity of reagents and lack of well-equipped labs including trained staff. Moreover, appropriate sample collection and transport, standard laboratory protocols, stringent quality control norms, good quality RNA extraction kits, PCR kits with suitable primers can help in improving accuracy of the test results. A careful assessment of clinical, radiological and molecular findings is required for identifying potential cases of COVID-19.

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread to nearly every corner of the globe, causing societal instability. The resultant coronavirus disease 2019 (COVID-19) leads to fever, sore throat, cough, chest and muscle pain, dyspnoea, confusion, anosmia, ageusia and headache. These can progress to life-threatening respiratory insufficiency, also affecting the heart, kidney, liver and nervous systems. The diagnosis of SARS-CoV-2 infection is often confused with that of influenza and seasonal upper respiratory tract viral infections. Due to available treatment strategies and required containments, rapid diagnosis is mandated. This Review brings clarity to the rapidly growing body of available and in-development diagnostic tests, including nanomaterial-based tools. It serves as a resource guide for scientists, physicians, students and the public at large.

sars cov 2 detection kit
                                                                                                sars cov 2 detection kit

Main

In the span of a few months, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was identified as the aetiological agent of coronavirus disease 2019 (COVID-19). Weeks later, viral diagnostic measures were deployed1. This served to supplement the common disease signs and symptoms of COVID-19 of cough, fever and dyspnoea. As all are seen during seasonal upper respiratory tract infections2, precise diagnostic tests detect viral nucleic acids, viral antigens or serological tests are required to affirm SARS-CoV-2 infection3. Chest computed tomography (CT) or magnetic resonance imaging (MRI) confirm disease manifestations2,3. The signature of COVID-19 is the life-threatening acute respiratory distress syndrome (ARDS)4. While the lung is the primary viral target, the cardiovascular, brain, kidney, liver and immune systems are commonly compromised by infection5. Thus, due to significant COVID-19 morbidity and mortality, containment of viral transmission through contact tracing, clinical assessment and virus detection was implemented through social distancing, face masks, contact isolation and hand hygiene to limit SARS-CoV-2 transmission6.

SARS-CoV-2 IgG Detection Kit (Colorimetric Trimer Anti-Spike IgG detection)

79975 96 rxns.
EUR 765
Description: The SARS-CoV-2 IgG detection kit is designed for qualitative detection of human IgG antibodies in serum collected from individuals suspected of prior infection with the virus that causes COVID-19. This fast and simple ELISA uses the trimeric form of the SARS-CoV-2 Spike protein (BPS Bioscience #100728) to identify IgG antibodies that indicate a previous infection with SARS-CoV-2. The Spike protein is expressed on the viral membrane as a trimer, which means this kit measures IgG antibodies in a more physiologically relevant context than many other commercially available ELISA kits. 

SeroFlash SARS-CoV-2 IgM/IgG Antibody Detection Kit

D-1001-025 25 tests
EUR 399.3

SeroFlash SARS-CoV-2 IgM/IgG Antibody Detection Kit

D-1001R-025 25 tests
EUR 399.3

SeroFlash SARS-CoV-2 IgM/IgG Antibody Detection Kit

D-1001R 25 Tests
EUR 377

Novel Coronavirus (SARS-CoV-2) Nucleic Acid Detection Kit

AGDK-0019 Kit Ask for price
Description: The Novel Coronavirus (SARS-CoV-2) Nucleic Acid Detection Kit is a real-time multiplex RT-PCR test intended for the qualitative detection of SARS-CoV-2 viral RNA. It is suitable for upper respiratory specimens, such as nasopharyngeal, oropharyngeal swab, and bronchoalveolar lavage specimens. In a single RT-PCR reaction, it is able to detect ORF1ab and N RNA sequences, and in addition, human RNase P as an internal control.

Monoclonal Antibody to SARS-CoV-2 Nucleocapsid Protein (Detection)

BSV-COV-AB-34 1 mg
EUR 1264
Description: Monoclonal Antibody to SARS-CoV-2 Nucleocapsid Protein (Detection)

Monoclonal Antibody to SARS-CoV-2 Nucleocapsid Protein (Detection)

BSV-COV-AB-35 1 mg
EUR 1264
Description: Monoclonal Antibody to SARS-CoV-2 Nucleocapsid Protein (Detection)

SARS Protein Detection Set

PSI-1810 1 Set
EUR 884.4
Description: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral S (Spike) protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. The M protein (Membrane protein, Matrix protein) is another major structural viral protein. It is an integral membrane protein involved in the budding of the viral particles and interacts with S protein and the nucleocapsid protein. The SARS E protein contains a short palindromic transmembrane helical hairpin that seems to deform lipid bilayers, which may explain its role in viral budding and virion envelope morphogenesis. ACE2, the SARS receptor, normally plays a central role in vascular, renal, and myocardial physiology. In contrast to its homolog ACE, ACE2 expression is restricted to heart, kidney, and testis.;;For images please see PDF data sheet

Monoclonal Antibody to SARS-CoV-2 Trimeric Spike Protein, linear epitope (Detection)

BSV-COV-AB-32 1 mg
EUR 2402
Description: Monoclonal Antibody to SARS-CoV-2 Trimeric Spike Protein, linear epitope (Detection)

Anti-SARS-CoV-2 Antibody IgG Quantitative Detection Kit (Spike RBD)

RAS-T049 96tests
EUR 845.3
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective Assay kit detecting the levels of anti-SARS-CoV-2 in human serum can facilitate research on characterization of antibodies produced in response to SARS-CoV-2 infection.

Anti-SARS-CoV-2 Antibody IgG Quantitative Detection Kit (Spike Trimer)

RAS-T048 96tests
EUR 845.3
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective Assay kit detecting the levels of anti-SARS-CoV-2 in human serum can facilitate research on characterization of antibodies produced in response to SARS-CoV-2 infection.

Anti-SARS-CoV-2 Neutralizing Antibody Quantitative Detection Kit (Spike RBD)

RAS-N044 96tests
EUR 845.3
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) poses continual threat to human health due to rapid transmission worldwide.Anti-SARS-CoV-2 Neutralizing Antibody Quantitative Detection Kit (Spike RBD)to test the protective neutralizing antibody levels in post-vaccination serum or convalescent serum.

Anti-SARS-CoV-2 Antibody IgG Quantitative and Titer Detection Kit (Spike RBD)

RAS-T093 96tests
EUR 845.3
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective Assay kit detecting the levels of anti-SARS-CoV-2 in human serum can facilitate research on characterization of antibodies produced in response to SARS-CoV-2 infection.

Anti-SARS-CoV-2 Antibody IgG Quantitative and Titer Detection Kit (Spike S1)

RAS-T095 96tests
EUR 845.3
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective Assay kit detecting the levels of anti-SARS-CoV-2 in human serum can facilitate research on characterization of antibodies produced in response to SARS-CoV-2 infection.

Anti-SARS-CoV-2 Antibody IgG Quantitative and Titer Detection Kit (Spike Trimer)

RAS-T094 96tests
EUR 845.3
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective Assay kit detecting the levels of anti-SARS-CoV-2 in human serum can facilitate research on characterization of antibodies produced in response to SARS-CoV-2 infection.

COVID19 PCR detection kit

BSV-qPCR-07 100 reactions
EUR 1201
Description: COVID19 PCR detection kit (detecting ORF1ab and N genes of SARS-COV-2 and human gene endogenous control)

COVID-19 Antigen Detection Kit

BSV-G61RHA20 20 tests
EUR 500
Description: COVID-19 Antigen Detection Kit

Biocredit Covid-19 Ag Detection Kit

G61RHA20 20 test cards (pkg)
EUR 114

SEB Detection Kit

6030 1 kit
EUR 377
Description: Liquid Samples

LPS Detection Kit

6039 1 kit
EUR 404
Description: Serum, Plasma

DAB Detection Kit

E-IR-R101-1mL 1mL
EUR 35

DAB Detection Kit

E-IR-R101-3mL 3mL
EUR 50

DAB Detection Kit

E-IR-R101-6mL 6mL
EUR 85

DAB Detection Kit

E-IR-R101-each each Ask for price

Fluorocescent Sarcosine Detection Kit

SARC100-2 100 Tests
EUR 345

HROS Detection Kit

FLAPF100-2 150 Tests
EUR 280

COVID-19 RT-qPCR Rapid Detection Kit

BSV-qPCR-06 100 reactions
EUR 695
Description: COVID-19 RT-qPCR Rapid Detection Kit

HMGB1 Detection Kit

6010 1 kit
EUR 500
Description: Serum, Plasma, Culture Media

DNase Detection Kit

PP-410L 500reactions
EUR 803.1

DNase Detection Kit

PP-410S 100reactions
EUR 200.8

Formaldehyde Detection Kit (2 Plate)

K001-F1 2x96 well plate
EUR 489
Description: Formaldehyde Detection assay Kit

Gliadin Detection Kit

6035 1 kit
EUR 377
Description: Liquid Samples

Autophagy Detection Kit

abx299014-50tests 50 tests
EUR 627.6

Autophagy Detection Kit

abx299015-200tests 200 tests
EUR 1045.2

Apoptosis Detection Kit

ANXVKB-100T 100 test
EUR 350.9
Description: The kit consists of the AnnexinV conjugated in the selected fluorochrome + solution for the exclusion of nonviable cells (PI) and Binding Buffer

Apoptosis Detection Kit

ANXVKCFB-100T 100 test
EUR 306.9
Description: The kit consists of the AnnexinV conjugated in the selected fluorochrome + solution for the exclusion of nonviable cells (PI) and Binding Buffer

Apoptosis Detection Kit

ANXVKCFB7-100T 100 test
EUR 306.9
Description: The kit consists of the AnnexinV conjugated in the selected fluorochrome + solution for the exclusion of nonviable cells (7AAD) and Binding Buffer

Apoptosis Detection Kit

ANXVKDY-100T 100 test
EUR 287.1
Description: The kit consists of the AnnexinV conjugated in the selected fluorochrome + solution for the exclusion of nonviable cells (PI) and Binding Buffer

Leave a Reply

Your email address will not be published. Required fields are marked *